Inhalable drug given green light

News

Author: Simge Eva DoganPublished: 9 January 2019

Prep: Cook: Serves:

The US Food and Drug Administration (FDA) has approved INBRIJA – an inhalable drug created by US biotech company Acorda Therapeutics – for intermittent treatment.

INBRIJA is designed to treat Parkinson’s symptoms that occur between oral doses of medication, which are known as ‘off’ episodes. The drug has been approved by the FDA and – after a clinical study involving 900 people with Parkinson’s – is expected to be available in 2019.

Todd Sherer, CEO of The Michael J Fox Foundation, who funded early trials of the powder, said: “Despite being on treatment, patients may experience OFF periods as Parkinson’s progresses, which can be disruptive.

“We knew we had to help address this unmet need, and this approval is a significant step forward for the community as it provides a new option to manage these gaps in symptom control.”

To read more on this topic click here.

For more information on Parkinson’s medication please visit the EPDA website.

Memory loss could be an indication of Parkinson’s

Last Month

Next Month

Go Back

Share this story

Comments

Resources & Tools

Parkinson’s podcast: losing our minds – cognition and PD

Fourth chat show examines psychological and cognitive problems

Tony’s two-wheel tour: Parkinson’s promise fulfilled, challenge completed!

Tony describes how he completed his Parkinson’s 100 Challenge

What to expect: the fourth World Parkinson Congress

We take a look at what you can expect in Portland

Research offers new insights on a cause of Parkinson’s disease

Researchers in Denmark have shared insights on a cause of up to 95% of Parkinson’s disease cases. Using data on gene patterns and three mouse models, scientists at the University of Copenhagen found that a blockage to a pathway regulating mitochondria (‘powerhouses’ that generate energy for reactions in cells) causes a form of the condition known as ‘sporadic Parkinson’s disease’. When the pathway becomes blocked by a protein, damaged mitochondria accumulate, unable to produce enough energy – which in turn causes nerve cells to die. “Just like when people eat, cells take what they need and get rid of … waste products,” explained corresponding study author Professor Shohreh Issazadeh-Navikas. “But if our brain cells have this specific kind of signalling blockage, it means that the powerhouse of the cell – mitochondria – cannot get cleaned up after being damaged.” The team now plan to investigate the pathway’s role in neuronal…

Could dance help to treat Parkinson’s disease?

Dance training with music could help slow the progression of mild-to-moderate Parkinson’s disease, researchers at York University in Canada have found. As part of the study, the researchers followed 16 participants with Parkinson’s disease who attended weekly dance classes between 2014 and 2017. The research team compared them to 16 people with Parkinson’s who did not take part in the classes. The research team found that the motor and non-motor symptoms of those who took part in the dance classes improved or did not progress over time – while those who did not participate showed a continual decline. “Dance is so complex,” said study author, PhD candidate Karolina Bearss. “It’s a multi-sensory type of environment. It incorporates and stimulates your auditory, tactile, visual and kinaesthetic senses and adds an interactive social aspect. Regular exercise does not offer these aspects. There’s so much more to dance.”

Vineyard pesticides may be linked to Parkinson’s disease

Exposure to pesticides used in vineyards could be linked to an increased risk of Parkinson’s disease, according to researchers in France. As part of their study, the team used a health insurance database to identify farmers in France who had been diagnosed with the condition. They then compared these records with data combining an agriculture census and pesticide expenditures across regions of varying farming types, including vineyards. They found that areas with vineyards that lacked designation of origin, and spent the most on pesticides, were associated with a 16% higher incidence of Parkinson’s. “This result suggests that agricultural practices and pesticides used in these vineyards may play a role in Parkinson’s disease,” the researchers concluded, “and that farmers in these farms should benefit from preventive measures aiming at reducing exposure.”

All fields required

First name*
Last name*
Email address*
Enter Email Confirm Email
Country of residence*
About me*
- I have Parkinson's disease
- I am a partner / carer / family / friend of someone who has Parkinson's
- I am a healthcare professional with an interest in Parkinson's
- I work for a Parkinson's disease organisation
- Other
CAPTCHA
*
- By proceeding you agree to our
Email
This field is for validation purposes and should be left unchanged.

Inhalable drug given green light

News

Author: Simge Eva DoganPublished: 9 January 2019

Prep: Cook: Serves:

Last Month

Next Month

Share this story

Comments

Resources & Tools

Parkinson’s podcast: losing our minds – cognition and PD

Europe

Tony’s two-wheel tour: Parkinson’s promise fulfilled, challenge completed!

Global update

What to expect: the fourth World Parkinson Congress

Research offers new insights on a cause of Parkinson’s disease

Could dance help to treat Parkinson’s disease?

Vineyard pesticides may be linked to Parkinson’s disease

{title}

Subscribe

Inhalable drug given green light

News

Author: Simge Eva DoganPublished: 9 January 2019

Prep: Cook: Serves:

Last Month

Next Month

Share this story

Comments

Related articles

Resources & Tools

Parkinson’s podcast: losing our minds – cognition and PD

Europe

Tony’s two-wheel tour: Parkinson’s promise fulfilled, challenge completed!

Global update

What to expect: the fourth World Parkinson Congress

Research offers new insights on a cause of Parkinson’s disease

Could dance help to treat Parkinson’s disease?

Vineyard pesticides may be linked to Parkinson’s disease

{title}

Subscribe

Sign in